Show simple item record

dc.contributor.authorGiagulli, Cinzia
dc.contributor.authorNoerder, Miriam
dc.contributor.authorAvolio, Manuela
dc.contributor.authorBecker, Pablo D
dc.contributor.authorFiorentini, Simona
dc.contributor.authorGuzman, Carlos A
dc.contributor.authorCaruso, Arnaldo
dc.date.accessioned2012-02-10T15:36:17Z
dc.date.available2012-02-10T15:36:17Z
dc.date.issued2009-11
dc.identifier.citationPidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. 2009, 9 (12):1366-73 Int. Immunopharmacol.en
dc.identifier.issn1878-1705
dc.identifier.pmid19712757
dc.identifier.doi10.1016/j.intimp.2009.08.010
dc.identifier.urihttp://hdl.handle.net/10033/210491
dc.description.abstractMucosal dendritic cells (DCs) are very important in the process of antigen presentation to T cells, playing a key role in the induction of primary and secondary immune responses. Pidotimod is a synthetic substance capable of modulating immune cell functions, but the effect of pidotimod on human DCs has not been investigated yet. Here we demonstrate the ability of pidotimod to induce DC maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are fundamental for communication with adaptative immunity cells. Pidotimod also stimulated DCs to release high amounts of pro-inflammatory molecules such as MCP-1 and TNF-alpha cytokines and to drive T cell proliferation and differentiation towards a Th1 phenotype. Moreover, we demonstrate that pidotimod in vivo promotes strong and specific humoral and cellular immune response when co-administered intranasally with a model antigen. Taken together our data suggest the possibility to use pidotimod as adjuvant molecule to facilitate the activation of the innate immune system as well as to promote an effective mucosal and systemic immune response.
dc.language.isoenen
dc.subject.meshAdjuvants, Immunologicen
dc.subject.meshAnimalsen
dc.subject.meshAntibody Formationen
dc.subject.meshAntigens, CDen
dc.subject.meshCell Differentiationen
dc.subject.meshCell Proliferationen
dc.subject.meshCells, Cultureden
dc.subject.meshChemokine CCL2en
dc.subject.meshCytotoxicity, Immunologicen
dc.subject.meshDendritic Cellsen
dc.subject.meshFemaleen
dc.subject.meshHLA-DR Antigensen
dc.subject.meshHumansen
dc.subject.meshLymphocyte Activationen
dc.subject.meshMiceen
dc.subject.meshMice, Inbred C57BLen
dc.subject.meshNasal Mucosaen
dc.subject.meshOvalbuminen
dc.subject.meshPeptide Fragmentsen
dc.subject.meshPyrrolidonecarboxylic Aciden
dc.subject.meshTh1 Cellsen
dc.subject.meshThiazolidinesen
dc.subject.meshTumor Necrosis Factor-alphaen
dc.titlePidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.en
dc.typeArticleen
dc.contributor.departmentDepartment of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, Medical School, Brescia, Italy.en
dc.identifier.journalInternational immunopharmacologyen
refterms.dateFOA2018-06-12T21:27:23Z
html.description.abstractMucosal dendritic cells (DCs) are very important in the process of antigen presentation to T cells, playing a key role in the induction of primary and secondary immune responses. Pidotimod is a synthetic substance capable of modulating immune cell functions, but the effect of pidotimod on human DCs has not been investigated yet. Here we demonstrate the ability of pidotimod to induce DC maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are fundamental for communication with adaptative immunity cells. Pidotimod also stimulated DCs to release high amounts of pro-inflammatory molecules such as MCP-1 and TNF-alpha cytokines and to drive T cell proliferation and differentiation towards a Th1 phenotype. Moreover, we demonstrate that pidotimod in vivo promotes strong and specific humoral and cellular immune response when co-administered intranasally with a model antigen. Taken together our data suggest the possibility to use pidotimod as adjuvant molecule to facilitate the activation of the innate immune system as well as to promote an effective mucosal and systemic immune response.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Giagulli et al_final.pdf
Size:
1.251Mb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record